Home Applications 019429 Application 019429
Type NDA
Sponsor ALLERGAN Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 003 FIORINAL W/CODEINE ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE CAPSULE;ORAL 325MG;50MG;40MG;30MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N019429-003 FIORINAL W/CODEINE ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE 325MG;50MG;40MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 1990-10-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N019429-003 FIORINAL W/CODEINE 325MG;50MG;40MG;30MG CAPSULE / ORAL RLD 1990-10-26 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N019429-003 FIORINAL W/CODEINE 325MG;50MG;40MG;30MG CAPSULE / ORAL RLD 1990-10-26 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N019429-003 FIORINAL W/CODEINE 325MG;50MG;40MG;30MG CAPSULE / ORAL RLD 1990-10-26 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N019429-003 FIORINAL W/CODEINE 325MG;50MG;40MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 1990-10-26 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 10 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0023-6010 Fiorinal with Codeine Butalbital, Aspirin, Caffeine, and Codeine Phosphate Allergan, Inc. NDA Current 0023-6010 Fiorinal with Codeine Butalbital, Aspirin, Caffeine, and Codeine Phosphate Allergan, Inc. NDA Current 0023-6010 Fiorinal with Codeine Butalbital, Aspirin, Caffeine, and Codeine Phosphate Allergan, Inc. NDA Current 0023-6010 Fiorinal with Codeine Butalbital, Aspirin, Caffeine, and Codeine Phosphate Allergan, Inc. NDA Current 0591-3546 Butalbital, Aspirin, Caffeine and Codeine Phosphate Butalbital, Aspirin, Caffeine and Codeine Phosphate Actavis Pharma, Inc. NDA AUTHORIZED GENERIC Current 0591-3546 Butalbital, Aspirin, Caffeine and Codeine Phosphate Butalbital, Aspirin, Caffeine and Codeine Phosphate Actavis Pharma, Inc. NDA AUTHORIZED GENERIC Current 0591-3546 Butalbital, Aspirin, Caffeine and Codeine Phosphate Butalbital, Aspirin, Caffeine and Codeine Phosphate Actavis Pharma, Inc. NDA AUTHORIZED GENERIC Current 0591-3546 Butalbital, Aspirin, Caffeine and Codeine Phosphate Butalbital, Aspirin, Caffeine and Codeine Phosphate Actavis Pharma, Inc. NDA AUTHORIZED GENERIC Current 0591-3546 Butalbital, Aspirin, Caffeine and Codeine Phosphate Butalbital, Aspirin, Caffeine and Codeine Phosphate Actavis Pharma, Inc. NDA AUTHORIZED GENERIC Current 52544-956 Fiorinal with Codeine Butalbital, Aspirin, Caffeine, and Codeine Phosphate Actavis Pharma, Inc. NDA Current